GAGabriela Aust

Gabriela Aust

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gabriela Aust has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Björn Vogel

    Department of Conservative Dentistry and Periodontology, University of Leipzig, Leipzig, Germany

    1 shared publication
  • D. Sittig

    Institute of Anatomy, Department of Surgery

    1 shared publication
  • Eike Schmücking

    Institute of Anatomy, University of Leipzig, Leipzig, Germany

    1 shared publication
  • Jörg Hamann

    Laboratory for Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    1 shared publication
  • M. Steinert

    Institute of Anatomy, Department of Surgery

    1 shared publication
  • Manja Wobus

    Institute of Anatomy, University of Leipzig, Leipzig, Germany

    1 shared publication

Latest Publications

  • Open Access

    N‐glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding

    by Manja Wobus, Björn Vogel, Eike Schmücking, Jörg Hamann, Gabriela Aust

    CD97 is an EGF‐TM7 receptor found on various carcinomas where expression levels correlate with dedifferentiation and tumor stage, smooth muscle cells and leukocytes. CD97 acts as an adhesion molecule by binding to its cellular ligand, CD55. In this study, we demonstrate that 2 immunodominant CD97 epitopes are not equally present in the various cell types. Differences were apparent in gastrointestinal tumors and smooth muscle cells where monoclonal antibodies (mAbs) to the first epidermal growth factor (EGF) domain (CD97EGF) showed a more restricted staining pattern than mAbs to the stalk region (CD97stalk). This discrepancy was not detectable in cultured gastrointestinal tumor cell lines. In fact, the selection of the CD97 mAb influences the result of clinical studies. Thus, we clarified the reason(s) for these differences in CD97 mAb staining on various cell types. We provide evidence that epitope accessibility for CD97EGF mAbs depends on N‐glycosylation. Immunoprecipitation of CD97 from the Colo 205 tumor cell line revealed the established 78 and 83 kDa products, while a 52 and 57 kDa band were obtained from smooth muscle cells. N‐glycosidase F reduced the size of CD97 in Colo 205 cells to 52–57 kDa. Culturing these cells with tunicamycin resulted in the same decrease in size and impaired CD97EGF mAb binding. As shown by site‐directed mutagenesis, deletion of the N‐glycosylation sites located within the EGF domains efficiently disturbed CD97EGF mAb immunoreactivity and, importantly, binding of CD55. In conclusion, CD97EGF epitope accessibility for mAbs and ligand binding is influenced by cell type‐specific N‐glycosylation.


  • Graves’ disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes

    by G. Aust, D. Sittig, M. Steinert, P. Lamesch, T. Lohmann

    The mechanisms by which T cells accumulate in the thyroid and support the autoimmune process in patients with Graves’ disease (GD) are poorly understood. Chemokines and their receptors may be involved in this process. We have analysed the expression of CXCR3 and CCR5 as Th1-specific chemokine receptors, CCR3 as a marker for Th2 cells, CXCR4 (expressed on unprimed, naive T cells) and CCR2 (known to be involved in autoimmunity) on peripheral blood (PBL) and thyroid-derived lymphocytes (TL) using flow cytometry. Chemokine receptor expression on PBL of GD patients (n = 16) did not differ from that of normal controls (n = 10). In GD, CXCR3+ (67·3 ± 4·0%versus 45·7 ± 2·1%) and CCR5+ T cells (42·5 ± 3·4%versus 18·8 ± 2·1%) showed a significant enrichment in the TL compared to PBL. The positive cells were contributed mainly by the CD4+CD45R0+ subset. TL are mostly primed CD45R0+ T cells, but surprisingly, they had significantly higher levels of CXCR4+ cells among TL (96·2 ± 1·0%) compared to PBL (66·8 ± 4·2%). However, CXCR4 has been induced during in vitro isolation of TL. There was no correlation between chemokine receptors and the level of TSH-receptor and thyroid peroxidase autoantibodies. CCR3+ and CCR2+ cells remained unchanged in TL compared to PBL. We could confirm the results using RT PCR and immunohistology. In summary, TL showed a different chemokine receptor pattern compared to PBL from the same patient. This indicates a role for CXCR3 and CCR5 in the recruitment of T cells to the thyroid in GD.